9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Reg. FD, Other Events
Reports Full-Year 2025 Operational Highlights and Financial Results
Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
Other Events
Unique Oncolytic Virus Therapies for Multiple Solid Tumors January 2026
Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Financial Results, Press Release
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence